Joanna Horobin
2018 - Idera Pharmaceuticals
Compensation breakdown
Non-Equity Incentive Plan | $72,250 |
---|---|
Option Awards | $461,837 |
Salary | $425,000 |
Other | $34,838 |
Total | $993,925 |
Horobin received $461.8K in option awards, accounting for 46% of the total pay in 2018.
Horobin also received $72.3K in non-equity incentive plan, $425K in salary and $34.8K in other compensation.
Rankings
In 2018, Joanna Horobin's compensation ranked 9,222nd out of 14,244 executives tracked by ExecPay. In other words, Horobin earned more than 35.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,222 out of 14,244 | 35th |
Division Manufacturing | 3,688 out of 5,765 | 36th |
Major group Chemicals And Allied Products | 1,386 out of 2,128 | 35th |
Industry group Drugs | 1,164 out of 1,817 | 36th |
Industry Biological Products, Except Diagnostic Substances | 224 out of 339 | 34th |
Pay ratio
Joanna Horobin's Pay | $993,925 |
---|---|
Median Employee's Pay | $297,391 |
Pay Ratio | 3to 1 |
In 2018, the annual total compensation of Joanna Horobin was $993,925.
The annual total compensation of the median employee at Idera Pharmaceuticals was $297,391.
The ratio of Joanna Horobin's pay to the pay of median employee was therefore 3 to one.
Horobin's colleagues
We found six more compensation records of executives who worked with Joanna Horobin at Idera Pharmaceuticals in 2018.
2018
Vincent Milano
Idera Pharmaceuticals
Chief Executive Officer
2018
Louis Arcudi
Idera Pharmaceuticals
Chief Financial Officer
2018
R Fletcher
Idera Pharmaceuticals
Senior Vice President, Business Development and Strategy
2018
Jonathan Yingling
Idera Pharmaceuticals
Chief Scientific Officer
2018
Bryant Lim
Idera Pharmaceuticals
General Counsel
2018
John Kirby
Idera Pharmaceuticals